Double-your-money opportunity at DexCom say analysts after near-40% stock crash
Healthcare kit maker DexCom (DXCM:NASDAQ) saw $15 billion swiped from its market value overnight after the company posted a big second quarter miss and slashed its Q3 guidance.
Previously valued at more than $42 billion, the San Diego, California-based firm saw its stock price plunge 37% in after-hours trading, leaving the market valuation at barely $27 billion.
UK investors may not be familiar...